In the United States alone, approximately 2 million people will contract a Hospital Acquired Infection (HAI) and 100,000 people will die each year. That is more than the two leading cancers combined.
  Surfacide® has changed the way UV-C technology is used in healthcare.  By implementing multiple light emitters in the patient environment, the Helios™ System overcomes the obstacles of using single emitter UV-C light systems.
  The HeliosTM System is the only evidence-based UV-C hard surface disinfection solution that is designed to overcome the demands presented by the Inverse Square Law.  Now, we don’t expect you to remember the laws of physics from your university days; however, what you do need to understand is that as distance increases, the amount of energy delivered to the surface is considerably reduced e.g. by a factor of 4.
  Surfacide® Helios™ System solves existing UV-C technology challenges by eliminating shadows in patient environments and reducing proximity to every high-touch surface. By implementing multiple light emitters in patient environments, the Helios™ System overcomes the obstacles of using single emitter UV-C light systems. The Surfacide® result: Better efficacy in less time and improved patient outcomes.
65483725b24c9a5d34bbce362e919804.jpg
30c9bb54465fa3da85019b6892a1c9ba.jpg
b32355dc509d54f749577bbc54b9e016.png
  Operated predominantly by environmental service employees with HSD education, the system control is designed around a simple touch interface via tablet controller. Connected to a central cloud-based database, the information collected will help track and further reduce the chance of infection. In the end, Surfacide®  will significantly reduce health providers costs and improve patient outcomes.
97454d690e18e906dd88ffbb97107d8e.png
prev / next